Incannex Healthcare Inc.
corporate_fare Company Profile
Incannex Healthcare Inc. (NASDAQ:IXHL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for IXHL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for IXHL spans 10-Q, 10-K, 8-K.
Recent high-impact activity:
- Incannex Quarterly Loss Blows Past Estimates as Revenue Stays at Zero
- Incannex Q1 Loss Narrows to $1.9M; Material Weakness Persists
- Incannex 10-K: Going Concern Removed, $67.7M Cash, But Material Weakness Persists
- Incannex Doses First Patient in DReAMzz Phase 2 Study of IHL-42X
- Final A$5.1M R&D Tax Refund Lands, Completing A$11.2M in Non-Dilutive Capital for 2026
Financial Snapshot
Short Interest & Short Volume
5.70 days to coverFINRA reported short interest of 358,009 shares in IXHL as of the October 30, 2026 settlement, a 13.0% decrease from the prior period — about 5.7 days to cover at its recent average daily volume. On November 20, 2026, 22.5% of IXHL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.